홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

(4s,5r)-1-{(2r,9e)-11-[3,17beta-Bis(benzyloxy)estra-1,3,5(10),9(11)-tetraen-11-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-9-undecenoyl}-3,4-dimethyl-5-phenylimidazolidin-2-one → (4S, 5R)-1-{(2R)-11-[3,17beta-Dihydroxyestra-1,3,5(10)-trien-11beta-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-undecanoyl}-3,4-dimethyl-5-phenylimidazolidin-2-one

HRID 1582837
인쇄

반응식

HRID 1582837 반응식
C([O:8][C:9]1[CH:26]=[CH:25][C:24]2[C:23]3[C@H:14]([C@H:15]4[C@@:19]([CH2:21][C:22]=3[CH2:27]/[CH:28]=[CH:29]/[CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][C@H:36]([CH2:53][CH2:54][C:55]([F:67])([F:66])[C:56]([F:65])([F:64])[C:57]([F:63])([F:62])[C:58]([F:61])([F:60])[F:59])[C:37]([N:39]3[C@H:43]([C:44]5[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=5)[C@H:42]([CH3:50])[N:41]([CH3:51])[C:40]3=[O:52])=[O:38])([CH3:20])[C@@H:18]([O:68]CC3C=CC=CC=3)[CH2:17][CH2:16]4)[CH2:13][CH2:12][C:11]=2[CH:10]=1)C1C=CC=CC=1.C(OC1C=CC2C3[C@H]([C@H]4[C@@](CC=3C/C=C\CCCCCC[C@H](CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(N3[C@H](C5C=CC=CC=5)[C@H](C)N(C)C3=O)=O)(C)[C@@H](OCC3C=CC=CC=3)CC4)CCC=2C=1)C1C=CC=CC=1>CO.O1CCCC1.[OH-].[OH-].[Pd+2]>[OH:8][C:9]1[CH:26]=[CH:25][C:24]2[C@@H:23]3[C@H:14]([C@H:15]4[C@@:19]([CH2:21][C@@H:22]3[CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][C@H:36]([CH2:53][CH2:54][C:55]([F:67])([F:66])[C:56]([F:64])([F:65])[C:57]([F:62])([F:63])[C:58]([F:59])([F:60])[F:61])[C:37]([N:39]3[C@H:43]([C:44]5[CH:45]=[CH:46][CH:47]=[CH:48][CH:49]=5)[C@H:42]([CH3:50])[N:41]([CH3:51])[C:40]3=[O:52])=[O:38])([CH3:20])[C@@H:18]([OH:68])[CH2:17][CH2:16]4)[CH2:13][CH2:12][C:11]=2[CH:10]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 2

HCID 86588541(4s,5r)-1-{(2r,9e)-11-[3,17beta-Bis(benzyloxy)estra-1,3,5(10),9(11)-tetraen-11-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-9-undecenoyl}-3,4-dimethyl-5-phenylimidazolidin-2-oneHCID 86588542(4S,5R)-1-[(2R,9Z)-11-[3,17beta-bis(benzyloxy)estra-1,3,5(10),9(11)-tetraen-11-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-9-undecenoyl}-3,4-dimethyl-5-phenylimidazolidin-2-one

생성물 1

HCID 86588540
(4S, 5R)-1-{(2R)-11-[3,17beta-Dihydroxyestra-1,3,5(10)-trien-11beta-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-undecanoyl}-3,4-dimethyl-5-phenylimidazolidin-2-one
수율 70%

시약·촉매·용매 3

HCID 9942167Palladium hydroxide촉매HCID 887Methanol용매HCID 8028Tetrahydrofuran용매

실험 절차

The mixture of (4S, 5R)-1-{(2R, 9E)-11-[3,17β-bis-(benzyloxy)estra-1,3,5(10), 9(11)-tetraen-11-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-9-undecenoyl}-3,4-dimethyl-5-phenylimidazolidin-2-one and (4S, 5R)-1-{(2R, 9Z)-11-[3,17β-bis(benzyloxy)estra-1,3,5(10), 9(11)-tetraen-11-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-9-undecenoyl}-3,4-dimethyl-5-phenylimidazolidin-2-one (283 mg, 0.27 mmol) was dissolved in a mixed solvent of methanol (12 ml) and tetrahydrofuran (1.2 ml), followed by addition of palladium hydroxide/carbon (85 mg) at room temperature. After purging with hydrogen, the reaction mixture was stirred for 1 day at room temperature. After the reaction mixture was filtered, the solvent was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=3/7) to give (4S, 5R)-1-{(2R)-11-[3,17β-dihydroxyestra-1,3,5(10)-trien-11β-yl]-2-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)undecanoyl}-3,4-dimethyl-5-phenylimidazolidin-2-one (164 mg, Yield 70%).

후처리

  1. customAfter purging with hydrogen
  2. filtrationAfter the reaction mixture was filtered
  3. concentrationthe solvent was concentrated under reduced pressure
  4. customThe residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=3/7)

출처 및 근거

ORD 기록
ord-ee4f554572f74093899af163151e00d1
출처 데이터셋
uspto-grants-2004_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06737417B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트